Location History:
- Stanford, CA (US) (2009 - 2014)
- Newton, MA (US) (2010 - 2022)
- Portola Valley, CA (US) (2018 - 2022)
Company Filing History:
7 out of 1,210 
6 out of 5,309 
2 out of 2,968 
Years Active: 2009-2022
Title: The Innovative Contributions of Rosemarie Dekruyff
Introduction
Rosemarie Dekruyff is a prominent inventor based in Portola Valley, California, whose extensive research has led to nine patents. Her work primarily focuses on biomedicine, particularly in the modulation of immune responses and cellular signaling pathways.
Latest Patents
Among her latest patents, Rosemarie has developed innovative agents that modulate RGMb-neogenin-BMP signaling. This invention covers compositions and methods designed for the modulation of these critical biological pathways. Another significant contribution is her patent on agents that modulate immune cell activation, detailing compositions and methods for immunomodulation mediated by the interaction of PD-L2 and RGMb. These pioneering inventions highlight her expertise in creating novel therapeutic strategies.
Career Highlights
Rosemarie has made substantial contributions during her tenure at prestigious institutions, including Dana-Farber Cancer Institute Inc. and Leland Stanford Junior University. Her role in these organizations has enabled her to explore cutting-edge research and develop transformative approaches in cancer treatment and immune response modulation.
Collaborations
Throughout her career, Rosemarie has collaborated with esteemed professionals, including her coworker Dale T Umetsu. These collaborations have been instrumental in advancing their mutual research interests and enhancing their innovative output.
Conclusion
Rosemarie Dekruyff's inventive spirit and dedication to advancing biomedical science through her patents exemplify her impact on the field. Her latest innovations have the potential to shape therapeutic approaches in immunology and cancer treatment, paving the way for future discoveries. As she continues her work, the scientific community eagerly anticipates her next groundbreaking contributions.